These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12968974)

  • 41. RT-PCR amplification of CK 20 mRNA in the peripheral blood of breast cancer patients: correlation with established prognostic parameters.
    Kim J; Bae JW; Lee JB; Son GS; Koo BH
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S380-3. PubMed ID: 16507414
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
    Miyoshi Y; Nakayama S; Torikoshi Y; Tanaka S; Ishihara H; Taguchi T; Tamaki Y; Noguchi S
    Cancer Sci; 2006 Jun; 97(6):523-9. PubMed ID: 16734731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
    Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
    Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
    Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
    Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
    Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
    IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer.
    Majima T; Ichikura T; Takayama E; Chochi K; Mochizuki H
    Jpn J Clin Oncol; 2000 Nov; 30(11):499-503. PubMed ID: 11155920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
    Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
    Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products.
    Zhong XY; Kaul S; Diel I; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 1999; 125(5):286-91. PubMed ID: 10359133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.
    Krismann M; Todt B; Schröder J; Gareis D; Müller KM; Seeber S; Schütte J
    J Clin Oncol; 1995 Nov; 13(11):2769-75. PubMed ID: 7595737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical significance of RT-PCR in detection of axillary lymph node micrometastases from breast cancer].
    Hao XB; Fu J; Qiu FH
    Ai Zheng; 2003 Sep; 22(9):964-7. PubMed ID: 12969530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.